Test results open door to new chapter for oral Covid drug

Successful development of the Pfizer and Merck pills, drugs known as Molnupiravir is being developed by Merck in partnership with Ridgeback Biotherapeutics, was not a given. Viruses use human cells to replicate, creating a challenge for scientists who aim ...

from Google Alert - Business https://ift.tt/31H0xR1
Successful development of the Pfizer and Merck pills, drugs known as Molnupiravir is being developed by Merck in partnership with Ridgeback Biotherapeutics, was not a given. Viruses use human cells to replicate, creating a challenge for scientists who aim ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize